Product Benefits

• Sustained Glycemic Control: The Modified-Release (MR) technology ensures the drug is released gradually over 24 hours, maintaining stable blood sugar levels with a single daily dose.

• Reduces Hypoglycemia Risk: Compared to immediate-release sulfonylureas, the MR formulation provides a more physiological insulin release, significantly lowering the risk of sudden low blood sugar (hypoglycemia).

• Vascular Protection: Gliclazide has unique hematological properties; it reduces microthrombosis (small blood clots) and improves the health of blood vessel linings, which helps prevent long-term diabetic complications.¹

• Organ Preservation: By strictly controlling blood glucose, it helps shield vital organs from damage, specifically reducing the risk of diabetic blindness (retinopathy) and kidney failure (nephropathy).²

• High Bioavailability: Glimicron-MR is completely absorbed by the body, and its absorption is not affected by food intake, ensuring consistent performance every day.

• Weight-Neutral Potential: While some diabetes medications cause significant weight gain, Gliclazide is often noted for having a more favorable weight profile among the sulfonylurea class.

• Simplified Dosing: The once-daily breakfast-time schedule improves patient compliance, making it easier to stick to a lifelong diabetes management plan.

Medical Disclaimer: Glimicron-MR 30mg is a prescription medication for Type 2 Diabetes only; it is not for Type 1 Diabetes.³ Always take it with your breakfast. Skipping meals after taking this tablet can lead to dangerous drops in blood sugar. It is contraindicated in patients with severe liver or kidney failure and during pregnancy. Frequent monitoring of blood glucose and ⁴$HbA1c$ is recommended.